Loading…

Miniaturizing bromodeoxyuridine incorporation enables the usage of flow cytometry for cell cycle analysis of adherent tissue culture cells for high throughput screening

Analysis of cell cycle progression by 5‐bromo‐2′‐deoxyuridine (BrdU) incorporation is commonly used for evaluating the mode of action of anticancer drugs, but usually requires a high number of cells and large amounts of monoclonal antibodies. In addition, manual sample handling is not suitable for h...

Full description

Saved in:
Bibliographic Details
Published in:Cytometry. Part A 2010-10, Vol.77A (10), p.953-961
Main Authors: Cappella, Paolo, Giorgini, Maria Laura, Ernestina Re, Claudia, Ubezio, Paolo, Ciomei, Marina, Moll, Jürgen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4052-a2c657e0fa36a69913d0c4a247f66497abec70de896f47c3432a849cb69716b63
cites cdi_FETCH-LOGICAL-c4052-a2c657e0fa36a69913d0c4a247f66497abec70de896f47c3432a849cb69716b63
container_end_page 961
container_issue 10
container_start_page 953
container_title Cytometry. Part A
container_volume 77A
creator Cappella, Paolo
Giorgini, Maria Laura
Ernestina Re, Claudia
Ubezio, Paolo
Ciomei, Marina
Moll, Jürgen
description Analysis of cell cycle progression by 5‐bromo‐2′‐deoxyuridine (BrdU) incorporation is commonly used for evaluating the mode of action of anticancer drugs, but usually requires a high number of cells and large amounts of monoclonal antibodies. In addition, manual sample handling is not suitable for high throughput. To circumvent these limitations, we have developed a miniaturized method to measure BrdU incorporation into DNA directly in 96‐wells plates. Adherent cells were grown in 96‐well plates in the absence or presence of compounds of interest. After BrdU pulse labeling or pulse chase, cells were harvested, transferred to polymerase chain reaction (PCR) V‐bottom plates, and fixed by adding methanol. DNA denaturation was performed directly in the plates by heat using a PCR thermocycler. BrdU incorporation was detected by indirect immunocytochemical staining, and cellular DNA was counterstained using propidium iodide. Samples were acquired by a BD FACSCalibur with BD Multiwells Auto sampler or BD HTS. We defined a dynamic range of the optimal cell number, for which cells maintained exponential growth up to 72 h. The assay was robust up to 30,000 cells per well. BrdU dot plots of cell cycle phases showed an excellent separation of cell populations, and DNA histograms showed a low coefficient of variation. Thermal denaturation was suitable for 96‐well plates to detect BrdU incorporation with a good signal‐to‐noise ratio, and cluster analysis allowed fingerprint readouts for drug sensitivity and mechanism of action as exemplified for paclitaxel and doxorubicin. This method provided rapid high‐throughput BrdU/DNA content analysis with high accuracy and reproducibility, accompanied by a reduction in reagent consumption. A critical step was identified as the standardization of DNA denaturation using a PCR thermocycler. Here,we show some applications of this method for cell cycle studies in drug discovery. © 2010 International Society for Advancement of Cytometry
doi_str_mv 10.1002/cyto.a.20962
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_849430140</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1017982106</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4052-a2c657e0fa36a69913d0c4a247f66497abec70de896f47c3432a849cb69716b63</originalsourceid><addsrcrecordid>eNp9kb1uFDEUhS0EIiHQUSN3UGQX_61nXaIVBKSgNKGgGnk8d3aMPPbiHyXDE_GYeHZDylS2rj5_PvZB6C0la0oI-2jmHNZ6zYiS7Bk6p5sNWwnFyfPHPWNn6FVKvwjhG8LZS3TGKFNESHWO_n633upcov1j_R53MUyhh3A_10lvPWDrTYiHEHW2wWPwunOQcB4Bl6T3gMOABxfu8BJjghxnPISIDThXR8YB1l67Odm0kLofIYLPONuUCmBTXL0ajng6Hhztfqz2GMp-PJSMk4kAvkZ7jV4M2iV487BeoB9fPt_uvq6ub66-7T5dr4wg9bWaGblpgAyaSy2VorwnRmgmmkFKoRrdgWlID1slB9EYLjjTW6FMJ1VDZSf5BXp_8h5i-F0g5XayacmnPYSS2goLTqgglfzwJEkJbdSWUbJIL0-oiSGlCEN7iHbSca5Qu7TYLt_X6vbYYsXfPZhLN0H_CP-vrQL8BNxZB_OTsnb38_bmpP0HTHGt9g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017982106</pqid></control><display><type>article</type><title>Miniaturizing bromodeoxyuridine incorporation enables the usage of flow cytometry for cell cycle analysis of adherent tissue culture cells for high throughput screening</title><source>Wiley</source><creator>Cappella, Paolo ; Giorgini, Maria Laura ; Ernestina Re, Claudia ; Ubezio, Paolo ; Ciomei, Marina ; Moll, Jürgen</creator><creatorcontrib>Cappella, Paolo ; Giorgini, Maria Laura ; Ernestina Re, Claudia ; Ubezio, Paolo ; Ciomei, Marina ; Moll, Jürgen</creatorcontrib><description>Analysis of cell cycle progression by 5‐bromo‐2′‐deoxyuridine (BrdU) incorporation is commonly used for evaluating the mode of action of anticancer drugs, but usually requires a high number of cells and large amounts of monoclonal antibodies. In addition, manual sample handling is not suitable for high throughput. To circumvent these limitations, we have developed a miniaturized method to measure BrdU incorporation into DNA directly in 96‐wells plates. Adherent cells were grown in 96‐well plates in the absence or presence of compounds of interest. After BrdU pulse labeling or pulse chase, cells were harvested, transferred to polymerase chain reaction (PCR) V‐bottom plates, and fixed by adding methanol. DNA denaturation was performed directly in the plates by heat using a PCR thermocycler. BrdU incorporation was detected by indirect immunocytochemical staining, and cellular DNA was counterstained using propidium iodide. Samples were acquired by a BD FACSCalibur with BD Multiwells Auto sampler or BD HTS. We defined a dynamic range of the optimal cell number, for which cells maintained exponential growth up to 72 h. The assay was robust up to 30,000 cells per well. BrdU dot plots of cell cycle phases showed an excellent separation of cell populations, and DNA histograms showed a low coefficient of variation. Thermal denaturation was suitable for 96‐well plates to detect BrdU incorporation with a good signal‐to‐noise ratio, and cluster analysis allowed fingerprint readouts for drug sensitivity and mechanism of action as exemplified for paclitaxel and doxorubicin. This method provided rapid high‐throughput BrdU/DNA content analysis with high accuracy and reproducibility, accompanied by a reduction in reagent consumption. A critical step was identified as the standardization of DNA denaturation using a PCR thermocycler. Here,we show some applications of this method for cell cycle studies in drug discovery. © 2010 International Society for Advancement of Cytometry</description><identifier>ISSN: 1552-4922</identifier><identifier>ISSN: 1552-4930</identifier><identifier>EISSN: 1552-4930</identifier><identifier>DOI: 10.1002/cyto.a.20962</identifier><identifier>PMID: 21290469</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adherent cells ; Antibodies, Monoclonal - analysis ; Antibodies, Monoclonal - metabolism ; Antineoplastic Agents - pharmacology ; BrdU, adherent cells ; Bromodeoxyuridine ; Bromodeoxyuridine - analysis ; Cell Count ; Cell cycle ; Cell Cycle - drug effects ; Cell Division - drug effects ; Cell Line, Tumor ; Cell number ; Cytometry ; Denaturation ; Doxorubicin ; Drug discovery ; Drugs ; Flow Cytometry ; Heat ; high-throughput screening ; High-Throughput Screening Assays - methods ; high‐throughput ; Humans ; Methanol ; Monoclonal antibodies ; Paclitaxel ; Polymerase chain reaction ; propidium iodide ; Standardization ; Thermal denaturation ; Tissue Culture Techniques</subject><ispartof>Cytometry. Part A, 2010-10, Vol.77A (10), p.953-961</ispartof><rights>Copyright © 2010 International Society for Advancement of Cytometry</rights><rights>Copyright © 2010 International Society for Advancement of Cytometry.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4052-a2c657e0fa36a69913d0c4a247f66497abec70de896f47c3432a849cb69716b63</citedby><cites>FETCH-LOGICAL-c4052-a2c657e0fa36a69913d0c4a247f66497abec70de896f47c3432a849cb69716b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21290469$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cappella, Paolo</creatorcontrib><creatorcontrib>Giorgini, Maria Laura</creatorcontrib><creatorcontrib>Ernestina Re, Claudia</creatorcontrib><creatorcontrib>Ubezio, Paolo</creatorcontrib><creatorcontrib>Ciomei, Marina</creatorcontrib><creatorcontrib>Moll, Jürgen</creatorcontrib><title>Miniaturizing bromodeoxyuridine incorporation enables the usage of flow cytometry for cell cycle analysis of adherent tissue culture cells for high throughput screening</title><title>Cytometry. Part A</title><addtitle>Cytometry A</addtitle><description>Analysis of cell cycle progression by 5‐bromo‐2′‐deoxyuridine (BrdU) incorporation is commonly used for evaluating the mode of action of anticancer drugs, but usually requires a high number of cells and large amounts of monoclonal antibodies. In addition, manual sample handling is not suitable for high throughput. To circumvent these limitations, we have developed a miniaturized method to measure BrdU incorporation into DNA directly in 96‐wells plates. Adherent cells were grown in 96‐well plates in the absence or presence of compounds of interest. After BrdU pulse labeling or pulse chase, cells were harvested, transferred to polymerase chain reaction (PCR) V‐bottom plates, and fixed by adding methanol. DNA denaturation was performed directly in the plates by heat using a PCR thermocycler. BrdU incorporation was detected by indirect immunocytochemical staining, and cellular DNA was counterstained using propidium iodide. Samples were acquired by a BD FACSCalibur with BD Multiwells Auto sampler or BD HTS. We defined a dynamic range of the optimal cell number, for which cells maintained exponential growth up to 72 h. The assay was robust up to 30,000 cells per well. BrdU dot plots of cell cycle phases showed an excellent separation of cell populations, and DNA histograms showed a low coefficient of variation. Thermal denaturation was suitable for 96‐well plates to detect BrdU incorporation with a good signal‐to‐noise ratio, and cluster analysis allowed fingerprint readouts for drug sensitivity and mechanism of action as exemplified for paclitaxel and doxorubicin. This method provided rapid high‐throughput BrdU/DNA content analysis with high accuracy and reproducibility, accompanied by a reduction in reagent consumption. A critical step was identified as the standardization of DNA denaturation using a PCR thermocycler. Here,we show some applications of this method for cell cycle studies in drug discovery. © 2010 International Society for Advancement of Cytometry</description><subject>Adherent cells</subject><subject>Antibodies, Monoclonal - analysis</subject><subject>Antibodies, Monoclonal - metabolism</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>BrdU, adherent cells</subject><subject>Bromodeoxyuridine</subject><subject>Bromodeoxyuridine - analysis</subject><subject>Cell Count</subject><subject>Cell cycle</subject><subject>Cell Cycle - drug effects</subject><subject>Cell Division - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Cell number</subject><subject>Cytometry</subject><subject>Denaturation</subject><subject>Doxorubicin</subject><subject>Drug discovery</subject><subject>Drugs</subject><subject>Flow Cytometry</subject><subject>Heat</subject><subject>high-throughput screening</subject><subject>High-Throughput Screening Assays - methods</subject><subject>high‐throughput</subject><subject>Humans</subject><subject>Methanol</subject><subject>Monoclonal antibodies</subject><subject>Paclitaxel</subject><subject>Polymerase chain reaction</subject><subject>propidium iodide</subject><subject>Standardization</subject><subject>Thermal denaturation</subject><subject>Tissue Culture Techniques</subject><issn>1552-4922</issn><issn>1552-4930</issn><issn>1552-4930</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kb1uFDEUhS0EIiHQUSN3UGQX_61nXaIVBKSgNKGgGnk8d3aMPPbiHyXDE_GYeHZDylS2rj5_PvZB6C0la0oI-2jmHNZ6zYiS7Bk6p5sNWwnFyfPHPWNn6FVKvwjhG8LZS3TGKFNESHWO_n633upcov1j_R53MUyhh3A_10lvPWDrTYiHEHW2wWPwunOQcB4Bl6T3gMOABxfu8BJjghxnPISIDThXR8YB1l67Odm0kLofIYLPONuUCmBTXL0ajng6Hhztfqz2GMp-PJSMk4kAvkZ7jV4M2iV487BeoB9fPt_uvq6ub66-7T5dr4wg9bWaGblpgAyaSy2VorwnRmgmmkFKoRrdgWlID1slB9EYLjjTW6FMJ1VDZSf5BXp_8h5i-F0g5XayacmnPYSS2goLTqgglfzwJEkJbdSWUbJIL0-oiSGlCEN7iHbSca5Qu7TYLt_X6vbYYsXfPZhLN0H_CP-vrQL8BNxZB_OTsnb38_bmpP0HTHGt9g</recordid><startdate>201010</startdate><enddate>201010</enddate><creator>Cappella, Paolo</creator><creator>Giorgini, Maria Laura</creator><creator>Ernestina Re, Claudia</creator><creator>Ubezio, Paolo</creator><creator>Ciomei, Marina</creator><creator>Moll, Jürgen</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201010</creationdate><title>Miniaturizing bromodeoxyuridine incorporation enables the usage of flow cytometry for cell cycle analysis of adherent tissue culture cells for high throughput screening</title><author>Cappella, Paolo ; Giorgini, Maria Laura ; Ernestina Re, Claudia ; Ubezio, Paolo ; Ciomei, Marina ; Moll, Jürgen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4052-a2c657e0fa36a69913d0c4a247f66497abec70de896f47c3432a849cb69716b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adherent cells</topic><topic>Antibodies, Monoclonal - analysis</topic><topic>Antibodies, Monoclonal - metabolism</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>BrdU, adherent cells</topic><topic>Bromodeoxyuridine</topic><topic>Bromodeoxyuridine - analysis</topic><topic>Cell Count</topic><topic>Cell cycle</topic><topic>Cell Cycle - drug effects</topic><topic>Cell Division - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Cell number</topic><topic>Cytometry</topic><topic>Denaturation</topic><topic>Doxorubicin</topic><topic>Drug discovery</topic><topic>Drugs</topic><topic>Flow Cytometry</topic><topic>Heat</topic><topic>high-throughput screening</topic><topic>High-Throughput Screening Assays - methods</topic><topic>high‐throughput</topic><topic>Humans</topic><topic>Methanol</topic><topic>Monoclonal antibodies</topic><topic>Paclitaxel</topic><topic>Polymerase chain reaction</topic><topic>propidium iodide</topic><topic>Standardization</topic><topic>Thermal denaturation</topic><topic>Tissue Culture Techniques</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cappella, Paolo</creatorcontrib><creatorcontrib>Giorgini, Maria Laura</creatorcontrib><creatorcontrib>Ernestina Re, Claudia</creatorcontrib><creatorcontrib>Ubezio, Paolo</creatorcontrib><creatorcontrib>Ciomei, Marina</creatorcontrib><creatorcontrib>Moll, Jürgen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cytometry. Part A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cappella, Paolo</au><au>Giorgini, Maria Laura</au><au>Ernestina Re, Claudia</au><au>Ubezio, Paolo</au><au>Ciomei, Marina</au><au>Moll, Jürgen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Miniaturizing bromodeoxyuridine incorporation enables the usage of flow cytometry for cell cycle analysis of adherent tissue culture cells for high throughput screening</atitle><jtitle>Cytometry. Part A</jtitle><addtitle>Cytometry A</addtitle><date>2010-10</date><risdate>2010</risdate><volume>77A</volume><issue>10</issue><spage>953</spage><epage>961</epage><pages>953-961</pages><issn>1552-4922</issn><issn>1552-4930</issn><eissn>1552-4930</eissn><abstract>Analysis of cell cycle progression by 5‐bromo‐2′‐deoxyuridine (BrdU) incorporation is commonly used for evaluating the mode of action of anticancer drugs, but usually requires a high number of cells and large amounts of monoclonal antibodies. In addition, manual sample handling is not suitable for high throughput. To circumvent these limitations, we have developed a miniaturized method to measure BrdU incorporation into DNA directly in 96‐wells plates. Adherent cells were grown in 96‐well plates in the absence or presence of compounds of interest. After BrdU pulse labeling or pulse chase, cells were harvested, transferred to polymerase chain reaction (PCR) V‐bottom plates, and fixed by adding methanol. DNA denaturation was performed directly in the plates by heat using a PCR thermocycler. BrdU incorporation was detected by indirect immunocytochemical staining, and cellular DNA was counterstained using propidium iodide. Samples were acquired by a BD FACSCalibur with BD Multiwells Auto sampler or BD HTS. We defined a dynamic range of the optimal cell number, for which cells maintained exponential growth up to 72 h. The assay was robust up to 30,000 cells per well. BrdU dot plots of cell cycle phases showed an excellent separation of cell populations, and DNA histograms showed a low coefficient of variation. Thermal denaturation was suitable for 96‐well plates to detect BrdU incorporation with a good signal‐to‐noise ratio, and cluster analysis allowed fingerprint readouts for drug sensitivity and mechanism of action as exemplified for paclitaxel and doxorubicin. This method provided rapid high‐throughput BrdU/DNA content analysis with high accuracy and reproducibility, accompanied by a reduction in reagent consumption. A critical step was identified as the standardization of DNA denaturation using a PCR thermocycler. Here,we show some applications of this method for cell cycle studies in drug discovery. © 2010 International Society for Advancement of Cytometry</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>21290469</pmid><doi>10.1002/cyto.a.20962</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-4922
ispartof Cytometry. Part A, 2010-10, Vol.77A (10), p.953-961
issn 1552-4922
1552-4930
1552-4930
language eng
recordid cdi_proquest_miscellaneous_849430140
source Wiley
subjects Adherent cells
Antibodies, Monoclonal - analysis
Antibodies, Monoclonal - metabolism
Antineoplastic Agents - pharmacology
BrdU, adherent cells
Bromodeoxyuridine
Bromodeoxyuridine - analysis
Cell Count
Cell cycle
Cell Cycle - drug effects
Cell Division - drug effects
Cell Line, Tumor
Cell number
Cytometry
Denaturation
Doxorubicin
Drug discovery
Drugs
Flow Cytometry
Heat
high-throughput screening
High-Throughput Screening Assays - methods
high‐throughput
Humans
Methanol
Monoclonal antibodies
Paclitaxel
Polymerase chain reaction
propidium iodide
Standardization
Thermal denaturation
Tissue Culture Techniques
title Miniaturizing bromodeoxyuridine incorporation enables the usage of flow cytometry for cell cycle analysis of adherent tissue culture cells for high throughput screening
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T12%3A15%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Miniaturizing%20bromodeoxyuridine%20incorporation%20enables%20the%20usage%20of%20flow%20cytometry%20for%20cell%20cycle%20analysis%20of%20adherent%20tissue%20culture%20cells%20for%20high%20throughput%20screening&rft.jtitle=Cytometry.%20Part%20A&rft.au=Cappella,%20Paolo&rft.date=2010-10&rft.volume=77A&rft.issue=10&rft.spage=953&rft.epage=961&rft.pages=953-961&rft.issn=1552-4922&rft.eissn=1552-4930&rft_id=info:doi/10.1002/cyto.a.20962&rft_dat=%3Cproquest_cross%3E1017982106%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4052-a2c657e0fa36a69913d0c4a247f66497abec70de896f47c3432a849cb69716b63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1017982106&rft_id=info:pmid/21290469&rfr_iscdi=true